Clinician's Roundtable

Presenter: Scott Sicherer, MD


Based on a randomized study, children with higher baseline thresholds of peanut reactivity achieved markedly higher rates of sustained unresponsiveness after oral immunotherapy compared with untreated peers. Learn more about this study and its clinical implications with Dr. Scott H. Sicherer. Not only is he a Professor of Pediatrics and the Director of the Jaffe Food Allergy Institute at the Icahn School of Medicine at Mount Sinai, but he also spoke about this topic at the 2026 American Academy of Allergy, Asthma, and Immunology Annual Meeting.

Presenter: Sally E. Wenzel, MD, ATSF


Given that severe asthma management is entering a new era of biologically driven precision, Dr. Sally Wenzel joins us to discuss the complexity within Type 2 inflammation and the limitations of relying on a single biomarker assessment. She also differentiates childhood-onset allergic asthma from adult-onset disease, underscoring how age of onset—along with underlying biology—can inform therapeutic strategy. Dr. Wenzel serves as the Director of the Asthma Institute at UPMC, and she spoke about this topic at the 2026 American Academy of Allergy, Asthma, and Immunology Annual Meeting.

Guest: Peter Buch, MD, FACG, AGAF, FACP


From early metabolic risks to advanced liver disease, the progressive burden associated with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) requires timely, informed care. Hear from Dr. Peter Buch as he shares practical guidance on intervention strategies and provides a closer look at current and emerging treatments shaping patient outcomes. Dr. Buch is a board-certified clinical gastroenterologist and Associate Professor at the Frank H. Netter, MD School of Medicine at Quinnipiac University.

Host: Alexandria May, PharmD, BCPS

Guest: Clay Spitler, MD


Fracture patients receiving anticoagulation therapy face increased risks for bleeding and complications, particularly when urgent surgical intervention is needed. That’s why understanding how fracture type, injury severity, and anticoagulant choice influence timing and management decisions is critical to optimizing outcomes. Joining Dr. Alexandria May to discuss bleeding risk assessment, anticoagulation reversal strategies, and the importance of coordinated, protocol-driven care for fracture patients on anticoagulation is Dr. Clay Spitler. He’s an orthopedic trauma surgeon and serves as Vice Chair of Clinical Affairs for the Department of Orthopedic Surgery at the University of Alabama at Birmingham.

Guest: Peter Buch, MD, FACG, AGAF, FACP


Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing liver health concern that's closely linked to obesity and other cardiometabolic risk factors, yet it remains underrecognized in clinical practice. That's why Dr. Peter Buch joins us to discuss how emerging perspectives are changing the way we think about metabolic-related liver disease. Dr. Buch is a board-certified clinical gastroenterologist and Associate Professor at the Frank H. Netter, MD School of Medicine at Quinnipiac University in Connecticut.